San Diego-dependent Viking Therapeutics marked by itself as a serious competitor in the weight loss drug sector in February immediately after revealing promising details from a mid-phase trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when supplied as a weekly injection As well as in March the co… Read More